Dominick Arena Joins Implandata Ophthalmic Products GmbH Board of Directors as Chairman

Published: Sep 19, 2018

Implandata logo

Hannover, Germany, September 18, 2018 / B3C newswire / -- Implandata Ophthalmic Products GmbH is pleased to announce that Dominick Arena is appointed as its Chairman of the Board effective immediately. Dominick is currently an Executive Advisor for Water Street Healthcare Partners, a strategic investor focused exclusively on the healthcare industry. He brings more than 30 years experience in the medical device industry.

Max Ostermeier, CEO of Implandata states: "The entire management team is extremely pleased that Dominick is joining our Board as Chairman. We look forward to closely working with him as we enter into a new and exciting phase with Implandata.  Dominick's operational and commercial experience will be of tremendous help as we begin the commercialization of our products. Further his M&A background will play a key role as we position the company for future strategic partnerships.”


About Implandata
Implandata is a privately held, ISO 13485 certified medical device company, which was founded in 2010 in Hannover/Germany. Implandata is a leader in the development of monitoring technologies for the treatment of Glaucoma. With the CE marked EYEMATE system, Implandata has developed the world-wide first solution for continual monitoring of intraocular pressure.

 
Contact

Implandata Ophthalmic Products GmbH
Max G. Ostermeier
Kokenstrasse 5
30159 Hannover, Germany
Phone: +49 551 2204 2581
Fax: +49 511 2204 2589
mostermeier@implandata.com

 

Posted by Sabine Duntze, B3C Group GmbH

 

Back to news